Aanjaneya Lifecare IPO GMP History
Aanjaneya Lifecare IPO has been listed on May 27, 2011 at a listing price of ₹218, against the issue price of ₹234 — a loss of ₹16 (-6.84%). The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Aanjaneya Lifecare IPO raised ₹117 Cr. through its IPO at a price band of ₹228 to ₹240 per share, with a lot size of 25 shares. The IPO was open for subscription from 09 May 2011 to 12 May 2011.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 12 Nov, 3:10 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| No GMP history available yet. | |||||
Aanjaneya Lifecare IPO dates
Key dates from opening to listing. Today is 12 November.
- Open 09 May 2011
- Close 12 May 2011
- Allotment 19 May 2011
- Refund/credit TBA
- Listing 27 May 2011
Aanjaneya Lifecare IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹234 |
|---|---|
| Listing gain / loss | −₹16 per share |
| Listing date | 27 May, 2011 |
| Actual listing price | ₹218 (-6.84%) |
Is Aanjaneya Lifecare IPO GMP reliable?
Grey market premium for Aanjaneya Lifecare IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Aanjaneya Lifecare IPO full review for a fundamentals-based assessment before making any grey market trades.
Aanjaneya Lifecare IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Aanjaneya Lifecare IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Aanjaneya Lifecare IPO
Aanjaneya Lifecare Limited is a research based integrated pharmaceutical company with research, manufacturing and marketing capabilities. Its promoters are Kannan Kashi Vishwanath and Aasda Life Care.
Its portfolio includes bulk drugs, finished dosage forms, herbal medicines, inhalers, lozenges and animal health products.
Its manufacturing facility at Mahad near Mumbai makes high end alkaloids, quinine salts, veterinary APIs and cytotoxic APIs.
The IPO was Rs 117 crore and was entirely fresh issue at Rs 234, within the Rs 228 to Rs 240 band. The money was for an anti cancer API facility, a cGMP API block, R&D expansion and a quality control block at Mahad.
Frequently asked
What is the GMP of Aanjaneya Lifecare IPO?
The current Grey Market Premium (GMP) of Aanjaneya Lifecare IPO is not yet started or active in the market.
What is the Kostak Price of Aanjaneya Lifecare IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Aanjaneya Lifecare IPO is not available.
What is the Subject to Sauda Price of Aanjaneya Lifecare IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Aanjaneya Lifecare IPO?
Aanjaneya Lifecare IPO listed on May 27, 2011 at ₹218, against the issue price of ₹234 — a loss of -6.84%.
How did the GMP of Aanjaneya Lifecare IPO trend before listing?
The GMP of Aanjaneya Lifecare IPO was stable in its final days before listing. View the day-wise table above for the complete GMP history.
Explore Aanjaneya Lifecare IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
